Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group

Noriyoshi Iriyama, Hitomi Nakayama, Masaru Nakagawa, Atsushi Takahata, Eriko Sato, Motoki Takano, Keigo Okada, Kohtaro Toyama, Toshiaki Hayashi, Takashi Abe, Keisuke Tanaka, Yasuhiko Senpuku, Yuki Osada, Junichi Watanabe, Koh Yamamoto, Yasunobu Sekiguchi, Gaku Oshikawa, Yuta Kimura, Michihide Tokuhira, Ken Suzuki, Takashi Kumagai, Takayuki Ikezoe, Shigeo Toyota, Katsuhiro Miura, Tomonori Nakazato, Takehiko Mori

Open source

DOI: 10.1007/s12185-025-04100-2
Published: 2025-11-09
Container: International Journal of Hematology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12185-025-04100-2,
  title = {Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group},
  author = {Noriyoshi Iriyama and Hitomi Nakayama and Masaru Nakagawa and Atsushi Takahata and Eriko Sato and Motoki Takano and Keigo Okada and Kohtaro Toyama and Toshiaki Hayashi and Takashi Abe and Keisuke Tanaka and Yasuhiko Senpuku and Yuki Osada and Junichi Watanabe and Koh Yamamoto and Yasunobu Sekiguchi and Gaku Oshikawa and Yuta Kimura and Michihide Tokuhira and Ken Suzuki and Takashi Kumagai and Takayuki Ikezoe and Shigeo Toyota and Katsuhiro Miura and Tomonori Nakazato and Takehiko Mori},
  year = {2025},
  journal = {International Journal of Hematology},
  doi = {10.1007/s12185-025-04100-2},
  url = {https://doi.org/10.1007/s12185-025-04100-2}
}

RIS

TY  - JOUR
TI  - Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group
AU  - Noriyoshi Iriyama
AU  - Hitomi Nakayama
AU  - Masaru Nakagawa
AU  - Atsushi Takahata
AU  - Eriko Sato
AU  - Motoki Takano
AU  - Keigo Okada
AU  - Kohtaro Toyama
AU  - Toshiaki Hayashi
AU  - Takashi Abe
AU  - Keisuke Tanaka
AU  - Yasuhiko Senpuku
AU  - Yuki Osada
AU  - Junichi Watanabe
AU  - Koh Yamamoto
AU  - Yasunobu Sekiguchi
AU  - Gaku Oshikawa
AU  - Yuta Kimura
AU  - Michihide Tokuhira
AU  - Ken Suzuki
AU  - Takashi Kumagai
AU  - Takayuki Ikezoe
AU  - Shigeo Toyota
AU  - Katsuhiro Miura
AU  - Tomonori Nakazato
AU  - Takehiko Mori
PY  - 2025
JO  - International Journal of Hematology
DO  - 10.1007/s12185-025-04100-2
UR  - https://doi.org/10.1007/s12185-025-04100-2
ER  -

APA

Iriyama, N., Nakayama, H., Nakagawa, M., Takahata, A., Sato, E., Takano, M., Okada, K., Toyama, K., Hayashi, T., Abe, T., Tanaka, K., Senpuku, Y., Osada, Y., Watanabe, J., Yamamoto, K., Sekiguchi, Y., Oshikawa, G., Kimura, Y., Tokuhira, M., Suzuki, K., Kumagai, T., Ikezoe, T., Toyota, S., Miura, K., Nakazato, T., & Mori, T. (2025). Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group. International Journal of Hematology. https://doi.org/10.1007/s12185-025-04100-2

Source records

crossref · retrieved 2026-09-27T14:15:57.905Z